Case Study: Large US Healthcare Company improves drug oversight and patient safety with Imprivata

Multistate healthcare system improves drug oversight and patient safety with Imprivata

A large US healthcare company, a multistate healthcare system operating 11 hospitals across five states, needed better visibility into drug diversion and wanted to replace manual, time-consuming investigations that increased patient safety risks. It turned to Imprivata and its FairWarning Drug Diversion Intelligence solution, along with Imprivata Drug Diversion Monitoring Services, to improve oversight and reduce diversion-related risks.

Imprivata implemented AI-based monitoring across ADC, EHR, and HCM data to automatically detect suspicious activity, streamline investigations, and support pharmacy operations with a dedicated analyst. The results included over a 60% reduction in null ADC transactions, about a 30% increase in waste compliance, and at least one FTE saved, with the Imprivata analyst reportedly saving the team 10 hours a day.